DE60130659D1 - Therapeutische verbindungen und verfahren - Google Patents

Therapeutische verbindungen und verfahren

Info

Publication number
DE60130659D1
DE60130659D1 DE60130659T DE60130659T DE60130659D1 DE 60130659 D1 DE60130659 D1 DE 60130659D1 DE 60130659 T DE60130659 T DE 60130659T DE 60130659 T DE60130659 T DE 60130659T DE 60130659 D1 DE60130659 D1 DE 60130659D1
Authority
DE
Germany
Prior art keywords
therapeutic compounds
compounds
therapy
compositions
well
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60130659T
Other languages
English (en)
Other versions
DE60130659T2 (de
Inventor
Barbara Martha Meurer-Grimes
Jin Yu
Gino Luigi Vairo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sarawak Government of State of Malaysia
Original Assignee
Sarawak Government of State of Malaysia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sarawak Government of State of Malaysia filed Critical Sarawak Government of State of Malaysia
Application granted granted Critical
Publication of DE60130659D1 publication Critical patent/DE60130659D1/de
Publication of DE60130659T2 publication Critical patent/DE60130659T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60130659T 2000-07-05 2001-07-05 Therapeutische verbindungen und verfahren Expired - Lifetime DE60130659T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP866500 2000-07-05
AUPQ8665A AUPQ866500A0 (en) 2000-07-05 2000-07-05 Therapeutic compounds and methods
PCT/AU2001/000810 WO2002002566A1 (en) 2000-07-05 2001-07-05 Therapeutic compounds and methods

Publications (2)

Publication Number Publication Date
DE60130659D1 true DE60130659D1 (de) 2007-11-08
DE60130659T2 DE60130659T2 (de) 2008-07-17

Family

ID=3822729

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60130659T Expired - Lifetime DE60130659T2 (de) 2000-07-05 2001-07-05 Therapeutische verbindungen und verfahren

Country Status (10)

Country Link
US (1) US6710075B2 (de)
EP (1) EP1303520B1 (de)
JP (1) JP2004501983A (de)
AT (1) ATE374203T1 (de)
AU (1) AUPQ866500A0 (de)
CA (1) CA2411818C (de)
DE (1) DE60130659T2 (de)
ES (1) ES2295176T3 (de)
PT (1) PT1303520E (de)
WO (1) WO2002002566A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1569928A4 (de) * 2002-11-08 2008-12-10 Government Of The State Of Sar Therapeutische verbindungen und verfahren
WO2006007634A1 (en) * 2004-07-16 2006-01-26 Cerylid Biosciences Ltd Processes and intermediates
EP2189158A1 (de) * 2008-11-20 2010-05-26 DKFZ Deutsches Krebsforschungszentrum, Stiftung des Öffentlichen Rechts Kombination aus Rocaglamid und Apoptose mit Substanzen zur Krebsbehandlung
WO2011140334A2 (en) * 2010-05-06 2011-11-10 Trustees Of Boston University Compounds, methods of making or identifying compounds, and uses thereof
FR3023290B1 (fr) * 2014-07-04 2016-08-19 Pf Medicament Derives de flavaglines
WO2017214024A1 (en) 2016-06-06 2017-12-14 Genentech, Inc. Silvestrol antibody-drug conjugates and methods of use
CN110279687A (zh) * 2019-07-15 2019-09-27 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 一种抗肿瘤药物
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
MY194199A (en) * 2020-08-11 2022-11-21 The Government Of The State Of Sarawak Malaysia A composition for the treatment of autoimmune diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656296A (en) 1983-06-01 1987-04-07 Sun Chemical Corporation Novel compounds and their use as insolubilizers for binders for paper coating compositions
IL114758A0 (en) 1994-08-04 1995-11-27 Ciba Geigy Ag Insecticidal polycyclic compounds
WO1997008161A1 (fr) 1995-08-28 1997-03-06 Terumo Kabushiki Kaisha Agent deprimant une fonction oncogenique
JPH0967360A (ja) 1995-08-28 1997-03-11 Terumo Corp 癌遺伝子機能抑制剤
JPH1112279A (ja) 1997-06-27 1999-01-19 Microbial Chem Res Found Ｒａｓ蛋白の阻害活性を有する新規なアグライアスタチン立体異性体とそれらの製造法
DE19934952A1 (de) * 1998-07-30 2000-02-03 Novartis Ag Cyclopentabenzofuran-Derivate
DE19835325A1 (de) * 1998-08-05 2000-02-10 Bayer Ag Verwendung von Cyclopentabenzofuran-Derivaten zur Bekämpfung von NF-kB abhängigen Krankheiten
DE19835324A1 (de) 1998-08-05 2000-02-10 Bayer Ag Cyclopentabenzofuran-Derivate und ihre Verwendung

Also Published As

Publication number Publication date
US6710075B2 (en) 2004-03-23
EP1303520B1 (de) 2007-09-26
US20030181514A1 (en) 2003-09-25
CA2411818C (en) 2011-02-22
DE60130659T2 (de) 2008-07-17
WO2002002566A1 (en) 2002-01-10
JP2004501983A (ja) 2004-01-22
CA2411818A1 (en) 2002-01-10
EP1303520A4 (de) 2005-03-30
ES2295176T3 (es) 2008-04-16
ATE374203T1 (de) 2007-10-15
EP1303520A1 (de) 2003-04-23
PT1303520E (pt) 2008-01-07
AUPQ866500A0 (en) 2000-08-03

Similar Documents

Publication Publication Date Title
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
GEP20084488B (en) Use of therapeutic agents for treating pain
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
ATE368018T1 (de) Gipszusammensetzungen und dazugehörende verfahren
DE60142473D1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
DE60030741D1 (de) Chinazoline verbindungen als heilmittel
ATE430555T1 (de) Pharmazeutische zusammensetzungen zur behandlung von asthma
NO20024610L (no) Synergistiske metoder og blandinger for behandling av kreft
RS49756B (sr) Primena ksenona ili smeša ksenonskog gasa za proizvodnju farmaceutskog preparata za lečenje neurointoksikacija
ATE450251T1 (de) Liposomale formulierungen mit dihydrosphingomyelin und verfahren zu ihrer verwendung
HUP0401190A3 (en) Treatment of nail infections using no generating compositions
MXPA04008068A (es) Metodo para administrar moleculas de glp-1.
ATE349446T1 (de) Amyloid plaque aggregationshemmer und diagnostische bilderzeugungsmittel
DK0765327T3 (da) Pyrazolo- og pyrrolopyridiner
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
AU5160201A (en) Compositions comprising natural agents for treatment of cancer
DE60105025D1 (de) Pharmazeutische verbindungen zur behandlung von chronisch-obstruktiver bronchopneumonie
NO20042208L (no) Vaginalt administrerte anti-dysrytmiske midler for behandling av bekkensmerter
EP1337255A4 (de) Verwendung von p38-inhibitoren zur behandlung von durch entzündungen verstärktem husten
DE60130659D1 (de) Therapeutische verbindungen und verfahren
DE60129829D1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
ATE312104T1 (de) Verbindungen zur behandlung von beeinträchtigten fundischen entspannung
BR0111785A (pt) Composições e métodos para tratamento de candidìase
EE200300213A (et) SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks
SE0004827D0 (sv) Therapeutic compounds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition